Acute decrease in renal microvascular PO2 during acute normovolemic hemodilution
Tanja Johannes, Egbert G Mik, Boris Nohé, Klaus E Unertl, Can Ince, Tanja Johannes, Egbert G Mik, Boris Nohé, Klaus E Unertl, Can Ince
Abstract
Large differences in the tolerance of organ systems to conditions of decreased O(2) delivery such as hemodilution exist. The kidney receives approximately 25% of the cardiac output and O(2) delivery is in excess of the oxygen demand under normal circumstances. In a rat model of acute normovolemic hemodilution (ANH), we studied the effect of reduced hematocrit on renal regional and microvascular oxygenation. Experiments were performed in 12 anesthetized male Wistar rats. Six animals underwent four steps of ANH (hematocrit 25, 15, 10, and <10%). Six animals served as time-matched controls. Systemic and renal hemodynamic and oxygenation parameters were monitored. Renal cortical (c) and outer medullary (m) microvascular PO(2) (microPO(2)) and the renal venous PO(2) (P(rv)O(2)) were continuously measured by oxygen-dependent quenching of phosphorescence. Despite a significant increase in renal blood flow in the first two steps of ANH, cmicroPO(2) and mmicroPO(2) dropped immediately. From the first step onward oxygen consumption (VO(2(ren))) became dependent on oxygen delivery (DO(2(ren))). With a progressive decrease in hematocrit, a significant correlation between microPO(2) and VO(2(ren)) could be observed, as well as a PO(2) gap between microPO(2) and P(rv)O(2). Furthermore, there was a high correlation between VO(2(ren)) and RBF over a wide range of flows. In conclusion, the oxygen supply to the renal tissue is becoming critical already in an early stage of ANH due to the combination of increased VO(2(ren)), decreased DO(2(ren)), and intrarenal O(2) shunt. This has clinical relevance as recent publications reporting that hemodilution during surgery forms a risk factor for postoperative renal dysfunction.
Source: PubMed
Bevorstehende klinische Studien
-
Seoul National University HospitalNoch keine Rekrutierung
-
Nanjing Medical UniversityRekrutierung
-
Minghui Pharmaceutical (Hangzhou) LtdNoch keine Rekrutierung
-
University of ChileRekrutierungHämophilie | Chronischer SchmerzChile
-
Medipol UniversityRekrutierungParkinson-Krankheit (PD)Türkei (türkiye)
-
University Hospital, MontpellierNoch keine RekrutierungHerzfehler | Diagnose | Medically Underserved AreaFrankreich
-
University Hospital, Basel, SwitzerlandSwiss National Science Foundation; Swiss GO Trial GroupNoch keine RekrutierungKrebsschmerz | Palliativversorgung bei KrebsSchweiz
-
First Affiliated Hospital of Fujian Medical UniversityNoch keine RekrutierungProstatakrebs | Biochemische Rezidive
-
Timothy MullettRekrutierungLungenkrebsvorsorgeVereinigte Staaten
-
Timothy MullettRekrutierungLungenkrebsvorsorgeVereinigte Staaten
-
Mansoura UniversityNoch keine RekrutierungTooth Loss and Rehabilitation With Telescopic Crown Prostheses
-
The Fourth Affiliated Hospital of Zhejiang University...Rekrutierung